-
| Exchange | PINK |
|---|---|
| ISIN | None |
| CurrencyCode | USD |
| Sector | |
| Industry |
| Market Cap | None |
|---|---|
| PE Ratio | None |
| Target Price | None |
| Beta | -0.09 |
| Dividend Yield | None |
Profusa, Inc. develops bioengineered sensors for body to detect and continuously transmit clinical-grade data for personal and medical use in the United States. The company offers the Lumee Oxygen Platform to monitor compromised tissue for peripheral artery disease, chronic wounds, and reconstructive surgery. It also researches and develops the Lumee Glucose Platform which is designed to monitor glucose levels in interstitial fluid. Profusa, Inc. is based in Berkeley, California.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for NVACW using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025